bace 1 inhibitor iv (calbiochem iv) (Millipore)
Millipore is a verified supplier 
90
Structured Review
Millipore
bace 1 inhibitor iv (calbiochem iv)
Bace 1 Inhibitor Iv (Calbiochem Iv), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bace+1+inhibitor+iv+(calbiochem+iv)/anti+bace1/pmc11341970-405-0-4
Average 90 stars, based on 1 article reviews
Bace 1 Inhibitor Iv (Calbiochem Iv), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bace+1+inhibitor+iv+(calbiochem+iv)/anti+bace1/pmc11341970-405-0-4
Average 90 stars, based on 1 article reviews
bace 1 inhibitor iv (calbiochem iv) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Unveiling the potential of novel indol-3-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors: a combined in silicosynthesis and in vitro study Article Snippet: Article Title: Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents Article Snippet: Article Title: Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors. Article Snippet: Alkaloids have always been a great source of cholinesterase inhibitors.. Numerous studies have shown that inhibiting acetylcholinesterase as well as butyrylcholinetserase is advantageous, and have better chances of success in preclinical/ clinical settings.. With the objective to discover dual cholinesterase inhibitors, herein we report synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine (1) and its bromo-derivative 2. Article Title: Hydantoins that modulate bace-mediated app processing Article Snippet: TABLE 1 Biological properties of illustrative hydantoins as compared to Article Title: Design, synthesis, in silicoand in vitro evaluation of pyrrol-2-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors Article Snippet: Article Title: Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent. Article Snippet: Funding information Council of Scientific and Industrial Research (CSIR, India), Grant/Award Number: P90807 (CSIR Young Scientist Award Grant) Abstract Beta-secreatse (BACE-1) and cholinesterases are clinically validated targets of Alzheimer's disease (AD), for which natural products have provided immense contribution.. The multifaceted nature of AD signifies the need of multitargeted agents to tackle this disease.. In the search of new natural products as dual BACE-1/cholinesterase inhibitors, a library of pure natural products was screened for inhibition of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and BACE-1. Article Title: Multifunctional agents against Alzheimer's disease based on oxidative stress: Polysubstituted pyrazine derivatives synthesized by multicomponent reactions. Article Snippet: As Alzheimer’s disease (AD) is a neurodegenerative disease with a complex pathogenesis, the exploration of multi-target drugs may be an effective strategy for AD treatment.. Multifunctional small molecular agents can be obtained by connecting two or more active drugs or privileged pharmacophores by multicomponent reactions (MCRs).. In this paper, two series of polysubstituted pyrazine derivatives with multifunctional moieties were designed as anti-AD agents and synthesized by Passerini-3CR and Ugi-4CR. Article Title: Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents. Article Snippet: Design, synthesis and biological evaluation of 1benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer’s agents Dawid Panek, Anna Wi#ckowska, Jakub Jo#czyk, Justyna Gody#, Marek W. Bajda, Tomasz Wichur, Anna Pasieka, Damijan Knez, Anja Pislar, Jan Korabecny, Ondrej Soukup, Vendula Sepsova, Raimon Sabaté, Janko Kos, Stanislav Gobec, and Barbara Malawska |